REFERENCIAS Biologic response modifiers in primary ... referenci… · Biologic response modifiers...

REFERENCIAS

Revisiones | Seres humanos | Animales | In vitro | Sobre factores de transferencia

Revisiones

1. 1. Bock K Transfer Factor: Immune System Modulators Autism/Asperger's Digest-2004.

2. Moss RW Cancer and complementary and alternative medicine in Italy: personal observations and historical considerations. Integr Cancer Ther-2004. 3(2);173-88

3. Singh VK Autoimmunity as Basis of Therapy for Autism In: Center for Autistic Spectrum Disorders Conference. Dallas, TX. -2003.

4. Kidd PM Autism, an extreme challenge to integrative medicine. Part 2: medical management. Altern Med Rev-2002. 7(6);472-99

5. Molife R, Hancock BW Adjuvant therapy of malignant melanoma. Crit Rev Oncol Hematol-2002. 44(1);81-102

6. [No Author(s)] Jarrow formulas: "colostrum specific" for cryptospordium. Posit Health News-2001.

7. [No Author(s)] Transfer factor. Posit Health News-2001. 8. Sosa Vazquez M, et al. [New concepts about atopic dermatitis] Rev

Alerg Mex-2001. 48(1);15-24 9. Bock SJ Transfer Factor and its Clinical Applications Rhinebeck Health

Center-2000. 10. Liubchenko TA, et al. [The biological activity of the transfer factor

induced by bacterial antigens] Mikrobiol Z-1998. 59(5);83-100 11. Salazar Villa RM, Mejia Ortega J [Use of transfer++factor in allergic

bronchial asthma] Rev Alerg-1997. 40(2);42-5 12. Bang D Treatment of Behcet's disease. Yonsei Med J-1997. 38(6);401-

10 13. Dwyer JM Transfer factor in the age of molecular biology: a review.

Biotherapy-1996. 9(1-3);7-11 14. Kirkpatrick CH Activities and characteristics of transfer factors.

Biotherapy-1996. 9(1-3);13-6 15. Levine PH The use of transfer factors in chronic fatigue syndrome:

prospects and problems. Biotherapy-1996. 9(1-3);77-9 16. Viza D AIDS and transfer factor: myths, certainties and realities.

Biotherapy-1996. 9(1-3);17-26 17. Katoch K Immunotherapy of leprosy. Indian J Lepr-1996. 68(4);349-61 18. Hicks P, et al. Azithromycin therapy for Cryptosporidium parvum

infection in four children infected with human immunodeficiency virus. J Pediatr-1996. 129(2);297-300

19. Ritchie DJ, Becker ES Update on the management of intestinal cryptosporidiosis in AIDS. Ann Pharmacother-1994. 28(6);767-78

20. Kirkpatrick CH Structural nature and functions of transfer factors. Ann N Y Acad Sci-1993. 685(0);362-8

21. Berthon P, Salmon H Immunological Factors in Mammary Secretions. Biologie de la Lactation. Institut National de la Recherche Agronomique. Versailles, France-1993.

22. Hassner A, Adelman DC Biologic response modifiers in primary immunodeficiency disorders. Ann Intern Med-1991. 115(4);294-307

23. Dwyer JM The rise and fall and rise again of transfer factor. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

24. Pekarek J, et al. The clinical use of specific transfer factors. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

Biologic response modifiers in primary immunodeficiency disorders. Hassner A, Adelman DC.

Structural nature and functions of transfer factors. Kirkpatrick CH.

A preliminary report on the use of transfer factor for treating stage D3 hormone-unresponsive metastatic prostate cancer. Pizza G, De Vinci C, Cuzzocrea D, Menniti D, Aiello E, Maver P, Corrado G, Romagnoli P, Dragoni E, LoConte G, Riolo U, Palareti A,

Zucchelli P, Fornarola V, Viza D.

Current status of thymosin research: evidence for the existence of a family of thymic factors that control T-cell maturation. Low TL, Thurman GB, Chincarini C, McClure JE, Marshall GD, Hu SK,

Goldstein AL.

Acute multifocal cerebral white matter lesions during transfer factor therapy. FRANCESCO G FOSCHI, LORENZO MARSIGLI, MAURO BERNARDI; FABRIZIO SALVI; MARIO MASCALCHI; GIOVANNI GASBARRIN; GIUSEPPE F

STEFANINI

Requirement of precommitted cells as targets for the augmentation of lymphocyte

http://www.transferfactorinstitute.com/International/Spanish/Research/references.cfm##http://www.transferfactorinstitute.com/International/Spanish/Research/references.cfm#human#humanhttp://www.transferfactorinstitute.com/International/Spanish/Research/references.cfm#animal#animalhttp://www.transferfactorinstitute.com/International/Spanish/Research/references.cfm#invitro#invitrohttp://www.transferfactorinstitute.com/International/Spanish/Research/references.cfm#tf#tfhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1854114http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1854114http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1854114http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1854114http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1854114http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8363241http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8363241http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8363241http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993770http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993770http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993770http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993770http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993770http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993770http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993770http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=394636http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=394636http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=394636http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=394636http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=394636http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=394636http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=394636http://jnnp.bmjjournals.com/cgi/content/full/68/1/114http://jnnp.bmjjournals.com/cgi/content/full/68/1/114http://jnnp.bmjjournals.com/cgi/content/full/68/1/114http://jnnp.bmjjournals.com/cgi/content/full/68/1/114http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=56417http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=56417http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=56417http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=56417http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=56417

25. Woodfield DG, et al. Transfer factor - Preparation, quality control and clinical use in New Zealand. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

26. Crusinberry R, Williams RD Immunotherapy of renal cell cancer. Semin Surg Oncol-1991. 7(4);221-9

27. Hadden JW Immunotherapy of human immunodeficiency virus infection. Trends Pharmacol Sci-1991. 12(3);107-11.

28. Gottlieb AA, Gottlieb MS Development of immunomodulators for treatment of HIV infection. Lymphology-1990. 23(2);98-101

29. Smogorzewska E [Transfer of delayed type hypersensitivity in guinea pigs] Probl Med Wieku Rozwoj-1990. 16(0);167-88

30. Kirkpatrick CH Biological response modifiers. Interferons, interleukins, and transfer factor. Ann Allergy-1989. 62(3);170-6

31. Fudenberg HH, Fudenberg HH Transfer factor: Past, Present and Future. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.

32. Soave R Clinical Cryptosporidiosis in Man. Proc 1st Int work. Edinburgh Animal Diseases Research Assoc.-1989.

33. Kirkpatrick CH Transfer factor. J Allergy Clin Immunol-1988. 81(5 Pt 1);803-13

34. Steele RW, Charlton RK Immune modulators as antiviral agents. Clin Lab Med-1987. 7(4);911-24

35. Purdy BD, Plaisance KI Current concepts in clinical therapeutics: immunologic treatment of human immunodeficiency virus infections. Clin Pharm-1987. 6(11);851-65

36. Fudenberg HH Transfer Factor: Past, present, and future. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.

37. Morescat Laboratory assays for TF. A critical overview. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.

38. Kirkpatrick CH Transfer factor: perspectives in human and veterinary medicine. J Exp Pathol-1987. 3(4);383-98

39. Spitler LE, Miller L Clinical trials of transfer factor in malignancy. J Exp Pathol-1987. 3(4);549-64

40. Solinger AM Indications for immunotherapy. Pharmacotherapy-1987. 7(2);S12-20

41. Pekarek J, Cech K [Transfer factor SEVAC - Perspectives of its medical application.] Zpravy SEVAC-1986. 1;3-36

42. Fan ZQ The immunity-regulating agent: Transfer factor. Conferernce for Appraisal of Transfer Factor-1985.

43. Drews J The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections. Infection-1985. 13 Suppl 2(0);S241-50

44. Fudenberg HH "Transfer factor": an update. Proc Soc Exp Biol Med-1985. 178(3);327-32

45. Gershon AA Symposium on infectious complications of neoplastic disease (Part II). Immunoprophylaxis of varicella-zoster infections. Am J Med-1984. 76(4);672-7

46. Kirkpatrick CH Host factors in defense against fungal infections. Am J Med-1984. 77(4D);1-12

47. Drews J The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections. Infection-1984. 12(2);157-66

48. Wilson GB, Fudenberg HH Is controversy about "transfer factor therapy" nearing an end? Immunol Today-1983. 4(6);157

49. Chase MW The immunological enigma of transfer factor. In:

Independent Articles

proliferation by leukocyte dialysates. Cohen L, Holzman RS, Valentine FT,

Lawrence HS

Nucleotide sequence analysis of two 5-nitroimidazole resistance determinants from Bacteroides strains and of a new insertion sequence upstream of the two genes. Haggoud A, Reysset G, Azeddoug

H, Sebald M.

Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy. Pilotti V, Mastrorilli M, Pizza G, De Vinci C, Busutti L, Palareti A,

Gozzetti G, Cavallari A.

Use of transfer factor for the treatment of recurrent non-bacterial female cystitis (NBRC): a preliminary report. De Vinci C, Pizza G, Cuzzocrea D, Menniti D, Aiello E, Maver P, Corrado G, Romagnoli P, Dragoni E, LoConte G, Riolo U, Masi M, Severini G, Fornarola V, Viza D.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8067736http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8067736http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8067736http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8067736http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8067736http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8067736http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8067736http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8067736http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8067736http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993769http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993769http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993769http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993769http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993771http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993771http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993771http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993771http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993771

Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.

50. Klesius PH Dialyzable leukocyte extract containing transfer factor--Its future in veterinary medicine. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.

51. Wilson GB, et al. Mechanism(s) of action of human transfer factor: Insights obtained from studying "Antigen-liberated transfer factor" specific for tuberculin. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.

52. Hughes RA Immunological treatment of multiple sclerosis. J Neurol-1983. 230(2);73-80

53. Massicot JG, Goldstein RA Transfer factor. Ann Allergy-1982. 49(6);326-9

54. Salaman MR The state of transfer factor. Immunology Today-1982. 3(1);4

55. Khan A, Hill NO [Unknown] In: Human Lymphokines, The Biological Immune Response Modifiers. Khan AK, Hill NO, Eds. Academic Press, NY-1982.

56. Svoboda J, et al. [Our experience with the therapeutic use of transfer factor] Vnitr Lek-1982. 28(10);1003-8

57. Casado de FrÃas E, et al. [Treatment of juvenile rheumatoid arthritis (author's transl)] An Esp Pediatr-1981. 15(1);48-62.

58. Pasternak G The present status of immunodiagnosis and immunotherapy of cancer. Arch Geschwulstforsch-1981. 51(4);284-93

59. Dienstag JL, Isselbacher KJ Therapy for acute and chronic hepatitis. Arch Intern Med-1981. 141(11);1419-23

60. Lawrence HS, Borkowsky W Transfer factor: recent developments in the pursuit of an idea. Cell Immunol-1981. 62(2);301-8

61. Lugwig S Indications and limitation of TF therapy Clin Immunol Allergy. North Holland Biochemical Press.-1981.

62. Arnold W, Meyer zum Buschenfelde KH [Therapy of chronic hepatitis (author's transl)] Leber Magen Darm-1981. 11(2);73-80

63. Krakowka S Developments in immunotherapy. Mod Vet Pract-1981. 62(6);447-51

64. Sobczyk W, Kulczycki J [Antiviral treatment of subacute sclerosing panencephalitis] Neurol Neurochir Pol-1981. 15(2);143-8

65. Sherlock S Treatment of chronic hepatitis. Ann Acad Med Singapore-1980. 9(2);185-7

66. Klesius PH, et al. Comparative studies on dialyzable leukocyte extracts containing transfer factor--a review. Comp Immunol Microbiol Infect Dis-1980. 3(3);247-60

67. Kirkpatrick CH Transfer factor. CRC Crit Rev Clin Lab Sci-1980. 12(2);87-122

68. Pizza G, et al. Transitional cell carcinoma of the bladder. Differences between primary tumour and following relapses. Eur Urol-1980.6(1);45-7

69. Auer IO [Therapy of chronic hepatitis (author's transl)] Leber Magen Darm-1980. 10(5);251-8

70. Kirkpatrick CH Therapeutic potential of transfer factor. N Engl J Med-1980. 303(7);390-1

71. Zdunczyk A [Transfer factor (its use in immunotherapy of neoplasms and other diseases)] Wiad Lek-1980. 33(11);877-81

72. Schroder I [Therapy with transfer factor in diseases with disorders of the cellular immune reaction] Z Gesamte Inn Med-1980. 35(2);86-91

73. Khan A The syndrome of asthma, recurrent viral infections and T-cell immunodeficiency: investigations and management. Ann Allergy-1979. 43(2);69-72

74. Burger DR, et al. A structural model for human transfer factor. Ann N Y

Acad Sci-1979. 332(0);236-40 75. Petersen EA, Kirkpatrick CH Nature and activities of transfer factor. Ann

N Y Acad Sci-1979. 332(0);216-27 76. Spitler LE Transfer factor in immunodeficiency diseases. Ann N Y Acad

Sci-1979. 332(0);228-35 77. Sutcliffe SB, et al. Transfer factor and immunity: an introduction. Ann N

Y Acad Sci-1979. 332(0);184-6 78. Ballow M, et al. Transfer factor, autoimmunity and T-cell immune

deficiencies. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

79. Marescot MR, et al. Quantification and biological assays of transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

80. Moulias R, et al. Transfer factor therapy in viral diseases: Results, adverse effects, indications. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

81. Di Padova F [A new approach to immunotherapy: the transfer factor] Minerva Med-1979. 70(25);1773-85

82. Edelman L, Reviron J [Technics and applications of transfer factor (author's transl)] Pathol Biol (Paris)-1979. 27(10);647-8

83. Rosman N Chronic mucocutaneous candidiasis. Postgrad Med J-1979. 55(647);611-4

84. Smogorzewska E [Levamisole as an immunostimulating factor] Probl Med Wieku Rozwoj-1979. 8(0);56-62

85. 85. Uotila A Transfer factor and other immunological activities of human leucocyte dialysate and other dialysates of mammalian tissues University of Tampere, Tampere-1979.

86. Schroder I [The current position of the transfer factor investigation (author's transl)] Allerg Immunol (Leipz)-1978. 24(4);243-53

87. Freedman RS, et al. Transfer factor and possible applications in gynecology. Am J Obstet Gynecol-1978. 130(5);572-84

88. Arala-Chaves MP, et al. Biological and clinical aspects of transfer factor. In: Immunological Engineering. Jirsch DW, Ed. MTP Press, London-1978.

89. Basten A, Croft S. Transfer factor: Clinical uasage and experimental studies. In: Immunological Engineering. Jirsch DW, Ed. MTP Press, London-1978.

90. Grob PJ Transfer factor. General aspects. Acta Neurol Scand Suppl-1977. 63(0);217-26

91. Warren SL Transfer factor for the practicing allergist-immunologist. Ann Allergy-1977. 39(2);130-2

92. Graziano FM, Dwyer JM Transfer factor--clinical enigma. History, preparation, properties and immunology of transfer factor. Conn Med-1977. 41(12);751-4

93. Mazaheri MR, et al. Immunotherapy of viral infections with transfer factor. J Med Virol-1977. 1(3);209-17

94. Rocha H ["Transfer factor" in ophthalmology (author's transl)] Klin Monatsbl Augenheilkd-1977. 171(1);63-70

95. Medunitsyn NV ["Transfer factor". Experimental findings and prospects for its clinical use] Patol Fiziol Eksp Ter-1977.

96. Kuhn HA [Therapy of hepatitis B. Practical implications] Schweiz Med Wochenschr-1977. 107(15);514-20

97. Fudenberg HH Dialyzable transfer factor in the treatment of human osteosarcoma: an analytic review. Ann N Y Acad Sci-1976. 277(00);545-57

98. Fudenberg HH, et al. Dialyzable transfer factor. An analytical review Folia Allerg Immunol-1976. 23;1

99. Erhan S On the nature of transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.

100. Lawrence HS Summation In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.

101. Novelli GD A biochemist's view of the mediators of cellular immunit, with special reference to transfer factor. In: Transfer Factor: Basic Properties and Clinical Applications. Ascher MS, Gottlieb AA, Kirkpatrick CH, Eds. Academic Press, NY-1976.

102. LoBuglio AF, Neidhart JA Transfer factor: a potential agent for cancer therapy. Med Clin North Am-1976. 60(3);585-90

103. Gröhn P Biological and chemical characterisation of human transfer factor Tampereen yliopisto, Tampere -1976.

104. Neidhart JA, LoBuglio AF Transfer factor: Potential for therapy of malignant diseases. Arch Otolaryngol-1975. 101(11);664-6

105. Hong R Thymus transplants: a look to the future. Birth Defects Orig Artic Ser-1975. 11(1);357-60

106. Levin AS, et al. Transfer factor I: methods of therapy. Birth Defects Orig Artic Ser-1975. 11(1);445-8

107. Spitler LE, et al. Transfer factor II: results of therapy. Birth Defects Orig Artic Ser-1975. 11(1);449-56

108. Scalise G "Transfer factor" therapy in infectious diseases. Boll Ist Sieroter Milan-1975. 54(6);502-5

109. Grob PJ Therapeutic use of transfer factor. Eur J Clin Invest-1975. 5(1);33-43

110. Kirkpatrick CH Properties and activities of transfer factor. J Allergy Clin Immunol-1975. 55(6);411-21

111. Florman AL, Holzman RS Nonspecific enhancers of resistance in man. J Pediatr-1975. 87(6 PT 2);1094-1102

112. Grob PJ, et al. [Transfer factor. Properties and possible therapeutic applications (author's transl)] MMW Munch Med Wochenschr-1975. 117(13);517-24

113. Shifrine M, Scibienski R Transfer factor - hypotheses for its structure and function. Oncology-1975. 32(5-6);269-74

114. Frey-Wettstein M, Grob PJ [Proceedings: Transfer factor--a preliminary report] Schweiz Med Wochenschr-1975. 105(51);1794-6

115. Maddison SE Dialyzable transfer factor. South Med J-1975. 68(12);1545-51

116. Basten A, et al. Uses of transfer factor. Vox Sang-1975. 28(4);257-77 117. Reymond JF, Grob PJ Transfer factor preparations: some physico-

chemical and biological properties. Vox Sang-1975. 29(5);338-51 118. Schroder I, et al. [The preparation and characterization of transfer factor

(author's transl)] Z Immunitatsforsch Exp Klin 119. Immunol-1975. 149(5);365-71 120. LoBuglio AF, Neidhart JA A review of transfer factor immunotherapy in

cancer. Cancer-1974. 34(4 Suppl);suppl:1563-70 121. Lawrence HS Transfer factor in cellular immunity. Harvey Lect-1974.

68(0);239-350 122. Burnet FM Transfer factor--a theoretical discussion. J Allergy Clin

Immunol-1974. 54(1);1-13 123. Dressler D, Rosenfeld S On the chemical nature of transfer factor. Proc

Natl Acad Sci U S A-1974. 71(11);4429-34 124. Zanelli JM Transfer factor--fact or fiction? Clin Sci Mol Med-1973.

45(3);19P 125. Grob PJ, et al. [Immune function and transfer factor] Dtsch Med

Wochenschr-1973. 98(9);446-51 126. Gottlieb AA, et al. What is transfer factor? Lancet-1973. 2(7833);822-3 127. Bloom BR Editorial: Does transfer factor act specifically or as an

immunologic adjuvant? N Engl J Med-1973. 288(17);908-9 128. Gottlieb AA Nature of "transfer factor". N Engl J Med-1973. 289(5);272 129. Hitzig WH, et al. [Transfer factor. Immunologic basis and therapeutic

experience] Schweiz Med Wochenschr-1972. 102(35);1237-44

130. Lawrence HS, Valentine FT Transfer factor and other mediators of cellular immunity. Am J Pathol-1970. 60(3);437-52

131. Lawrence HS Transfer factor and autoimmune disease. Ann N Y Acad Sci-1965. 124(1);56-60

Seres humanos

1. Morfin Maciel BM [Demodicidosis in a female patient treated as allergic blepharoconjunctivitis. A case report] Rev Alerg Mex-2004. 50(6);232-6

2. Orozco TT, et al. [Inflammatory mediators in patients with atopic dermatitis after treatment with transfer factor] Rev Alerg Mex-2004. 51(4);151-4

3. Beltran de Paz C, et al. [Psychological, immunological, and endocrinological implications of atopic dermatitis] Rev Alerg Mex-2003. 50(2);54-9

4. Garcia Angeles J, et al. [Lymphocyte apoptosis in atopic dermatitis treated with transfer factor] Rev Alerg Mex-2003. 50(1);3-7

5. See D, et al. Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers. Immunol Invest-2002. 31(2);137-53

6. Sosa M, et al. [Comparative treatment between thalidomide and transfer factor in severe atopic dermatitis] Rev Alerg Mex-2001. 48(2);56-64

7. Jia WC, et al. [Immune functional changes in patients of acute Henoch-Schonlein purpura and regulatory effect of integrated Traditional Chinese and Western medicine on it] Zhongguo Zhong Xi Yi Jie He Za Zhi-2001. 21(8);585-7

8. Cordero Miranda MA, et al. [Safety and efficacy of treatment for severe atopic dermatitis with cyclosporin A and transfer factor] Rev Alerg Mex-1999. 46(2);49-57

9. Estrada-Parra S, et al. Comparative study of transfer factor and acyclovir in the treatment of herpes zoster. Int J Immunopharmacol-1998. 20(10);521-35

10. Simko M, et al. [Immunomodulatory therapy of epilepsy with transfer factor] Bratisl Lek Listy-1997. 98(4);234-7

11. Chen N, et al. [Oral candidiasis in Sjogren's syndrome: prevalence, clinical features and treatment] Hua Xi Kou Qiang Yi Xue Za Zhi-1997. 15(3);239-41

12. Valdes Senchez AF, et al. [Treatment of extrinsic bronchial asthma with transfer factor] Rev Alerg Mex-1997. 40(5);124-31

13. Ablashi DV, et al. Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports. Biotherapy-1996. 9(1-3);81-6

14. Byston J, et al. Effect of anti-herpes specific transfer factor. Biotherapy-1996. 9(1-3);73-5

15. De Vinci C, et al. Lessons from a pilot study of transfer factor in chronic fatigue syndrome. Biotherapy-1996. 9(1-3);87-90

16. De Vinci C, et al. Use of transfer factor for the treatment of recurrent non-bacterial female cystitis (NBRC): a preliminary report. Biotherapy-1996. 9(1-3);133-8

17. Fudenberg HH Dialysable lymphocyte extract (DLyE) in infantile onset autism: a pilot study. Biotherapy-1996. 9(1-3);143-7

18. Gottlieb AA, et al. Rationale and clinical results of using leucocyte-derived immunosupportive therapies in HIV disease. Biotherapy-1996. 9(1-3);27-31

19. Hana I, et al. The influence of age on transfer factor treatment of cellular immunodeficiency, chronic fatigue syndrome and/or chronic viral infections. Biotherapy-1996. 9(1-3);91-5

20. Masi M, et al. Transfer factor in chronic mucocutaneous candidiasis. Biotherapy-1996. 9(1-3);97-103

21. Meduri R, et al. Efficacy of transfer factor in treating patients with recurrent ocular herpes infections. Biotherapy-1996. 9(1-3);61-6

22. Nevsimal O, et al. An attempt to inhibit the course of amyotrophic lateral sclerosis (ALS) by suppressor factor. Biotherapy-1996. 9(1-3);139-41

23. Ojeda Ojeda M, et al. Dialysable leucocyte extract (DLE) reduces lipopolysaccharide-induced tumour necrosis factor secretion in human leucocytes. Biotherapy-1996. 9(1-3);163-70

24. Pilotti V, et al. Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy. Biotherapy-1996. 9(1-3);117-21

25. Pizza G, et al. Preliminary observations using HIV-specific transfer factor in AIDS. Biotherapy-1996. 9(1-3);41-7

26. Pizza G, et al. In vitro studies during long-term oral administration of specific transfer factor. Biotherapy-1996. 9(1-3);175-85

27. Pizza G, et al. A preliminary report on the use of transfer factor for treating stage D3 hormone-unresponsive metastatic prostate cancer. Biotherapy-1996. 9(1-3);123-32

28. Pizza G, et al. Orally administered HSV-specific transfer factor (TF) prevents genital or labial herpes relapses. Biotherapy-1996. 9(1-3);67-72

29. Prasad U, et al. Transfer factor with anti-EBV activity as an adjuvant therapy for nasopharyngeal carcinoma: a pilot study. Biotherapy-1996. 9(1-3);109-15

30. Raise E, et al. Preliminary results in HIV-1-infected patients treated with transfer factor (TF) and zidovudine (ZDV). Biotherapy-1996.9(1-3);49-54

31. Fujisawa T, Yamaguchi Y Postoperative immunostimulation after complete resection improves survival of patients with stage I nonsmall cell lung carcinoma. Cancer-1996. 78(9);1892-8

32. Colagiuri S, et al. Intravenous immunoglobulin therapy for autoimmune diabetes mellitus. Clin Exp Rheumatol-1996. 14 Suppl 15(0);S93-7

33. Navarro Cruz D, et al. [Transference factor in moderate and severe atopic dermatitis] Rev Alerg Mex-1996. 43(5);116-23

34. Estrada-Parra S, et al. Immunotherapy with transfer factor of recurrent herpes simplex type I. Arch Med Res-1995. 26 Spec No(0);S87-92

35. Pizza G, et al. Transfer factor prevent relapse in herpes keratitis patients: A pilot study. Biotherapy-1995. 8;1-6

36. Sizemore RC, et al. A novel methodology for quantitating the enhancement of cutaneous delayed-type hypersensitivity by IMREG-1: a measure of the immunopotentiation of cell-mediated immunity. Clin Immunol Immunopathol-1995. 76(3 Pt 1);308-13

37. Ji T, et al. [Hepatic artery chemotherapy-embolization and biological response modifiers for late hepatic carcinoma] Zhonghua Zhong Liu Za Zhi-1995. 17(2);129-31

38. Pizza G, et al. Transfer factor prevents relapses in herpes keratitis patients: a pilot study. Biotherapy-1994. 8(1);63-8

39. Ferrer-Argote VE, et al. Successful treatment of severe complicated measles with non-specific transfer factor. In Vivo-1994. 8(4);555-7

40. Lloyd AR, et al. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med-1993. 94(2);197-203

41. Fernandez O, et al. Effect of transfer factor on myelosuppression and related morbidity induced by chemotherapy in acute leukaemias. Br J Haematol-1993. 84(3);423-7

42. Orosi P, Nugent K Studies of phagocytic and killing activities of alveolar macrophages in patients with sarcoidosis. Lung-1993. 171(4);225-33

43. Fazio M, et al. Transfer in vivo of tuberculin hypersensitivity by sensitised lymphocytes. Panminerva Med-1993. 35(3);149-53

44. Fazio M, et al. Transfer in vitro of tubercolin hypersensitivity by sensitised lymphocytes. Panminerva Med-1993. 35(2);96-100

45. Li JF, Zou ZW [Effects of the jianpi yiqi prescription in treating infantile

repetitive respiratory infection] Zhongguo Zhong Xi Yi Jie He Za Zhi-1993. 13(10);594-6, 579-80

46. Whyte RI, et al. Adjuvant treatment using transfer factor for bronchogenic carcinoma: long-term follow-up. Ann Thorac Surg-1992. 53(3);391-6

47. Prucha M, Limberk B [Secondary post-traumatic immunodeficiency syndrome in patients in the anesthesiology-resuscitation department. Possibilities of immunomodulation therapy] Cesk Epidemiol Mikrobiol Imunol-1992. 42(3);116-20

48. Xiuxin X. Observation of curative effect curing scleroderma with transfer factor of health person. In: [Unknown]-1992.

49. Fujisawa T, et al. [Recent advances of surgical treatment in elderly lung cancer patients] Nihon Kyobu Shikkan Gakkai Zasshi-1992. 30(2);224-9

50. Wu S, Zhong X [Observation of the effect of PSTF oral liquor on the positive tuberculin test reaction] Zhongguo Yi Xue Ke Xue Yuan Xue Bao-1992. 14(4);314-6

51. Sumiyama K, et al. Combination therapy with transfer factor and high dose stronger neo-minophagen C in chronic hepatitis B in children (HBe Ag positive). Acta Paediatr Jpn-1991. 33(3);327-34

52. Gottlieb MS, et al. Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. A multicenter, double-blind, placebo-controlled trial. Ann Intern Med-1991. 115(2);84-91

53. Tan ST, et al. Recurrent orf in an immunocompromised host. Br J Plast Surg-1991. 44(6);465-7

54. VeselskÃ¡ A, et al. [Mucosal candidiasis] Cas Lek Cesk-1991. 130(18-19);561-2

55. Nevsimal O, et al. [Low-molecular transfer factor and its use in the treatment of amyotrophic lateral sclerosis] Cesk Neurol Neurochir-1991. 54(4);220-2

56. Mydlil J [Treatment of Hodgkin's malignant lymphoma in children and adolescents by immunomodulation with a dialysate of human leukocytes] Cesk Pediatr-1991. 46(5);266-9

57. Akasawa A, et al. Clinical and immunological evaluations of oral transfer factor treatment on patients with atopic dermatitis and aphthous stomatitis. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

58. Baba M, et al. Postsurgical adjuvant immunotherapy for non-smallcell lung carcinomas. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

59. Baolai H, Jingxin W Clinical observation on the effects of dialyzable leukocyte extracts. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

60. Baoqun L, et al. Transfer factor and thymosin in the treatment Guillan-Barre's syndrome. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

61. Dwyer JM, et al. A controlled trial of dialysable leucocyte extracts (DLE) in the management of newly diagnosed insulin dependent diabetes mellitus. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

62. Fucikova T, et al. DLE in immunosuppresed patients. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

63. Gottlieb AA, Gottlieb MS Clinical and biological effects of IMREG-1 and

IMREG-2, two immunologically active components of leukocytedialysates. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, KomatsuF, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

64. Guang-Shu Z, et al. Evaluation of the effects of acute hepatitis B treated with specific placenta transfer factor. In: Recent Advancesin Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

65. Haiyan Q, et al. HSV-1 specific transfer factor for the treatment of herpes simplex keratitis. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

66. Jaji Z, et al. Therapeutic effects of acupoint injection of transfer factor on bronshial asthma In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

67. Jian-nan P, et al. Effect of transfer factor on oral mucous ulcer. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

68. Jing-Xin W, Ju-Xiang L Treatment on hepatitis B with bovine spleen transfer factor. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

69. Karl M, et al. Immunotherapy of women with recurrent spontaneous abortions by human large pool dialyzable leukocyte extract (DLE) In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

70. Li-Yi P, et al. Efficiency and immunological function observation on 100 cases malignant tumour with dialyzable placenta extracts. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

71. Matsumoto S, et al. Treatment of chronic persistent hepatitis B with high dose of specific dialyzable leukocyte extracts. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

72. Mayer V, et al. Marked therapeutic effect of human leukocyte ultrafiltrate in herpes zoster: Association with cell-mediated immune response induction. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

73. Metzner G, et al. Effect of DLE in patients suffered from chronic active and chronic persistent HBs-antigen-positive hepatitis. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

74. Pekarek J, et al. The use of DLE-TF fraction with the suppressive effect in some autoaggressive disease. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co.,LTD., Tokyo-1991.

75. Rovensky J, et al. DLE in the therapy of juvenile chronic arthritis. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

76. Rovensky J, et al. Wegner's granulomatosis: Some comments on the

diagnosis and therapy. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

77. Shi-Liang L, et al. The experimental study on the immune-activity of oral pig's spleen transfer factor (PS-TF) in human body. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

78. Sumiyama K, et al. Combined therapy with transfer factor and large dose SNMC in juvenile chronic hepatitis type B (Hbe Ag positive) In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

79. Takenouchi K, Sasakawa S Effects of dialyzable leukocyte extracts (DLE) on survival curves of subacute sclerosing panencephalitis (SSPE) patients. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, SasakawaS, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

80. Tatsuzawa O, et al. Clinical application of a transfer factor suppository. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

81. Wei-zhong W, et al. The effects of swine spleen transfer factor on the subset of T lymphocyte and cell factor in the patients with cancer of large intestine. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

82. Xiaolan L, et al. Treatment of recurrent acute tonsillitis with bovine spleen dialyzable leucocyte extract In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co.,LTD., Tokyo-1991.

83. Ya-ge L, et al. Study of immune action for transfer factor and interferon. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

84. Yizhen F, et al. Evaluation of the clinical and immunological effects of transfer factor (TF), thymosin (TH) and placonta factor (PF) onasthma in children. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

85. Yizhen F, et al. Effects and immunological analysis of transfer factor (TF) and placent facter (PF) on Guillain-Barre's syndrome (GBS) in children. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

86. Yuexing L, et al. Study of transfering delayed type hypersensitivity by dialyzable human placenta extract. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co.,LTD., Tokyo-1991.

87. Zhenqing F, et al. Comparison of the effectiveness between porcine and human spleen transfer factors in the treatment of bronchialasthma. In: Recent Advances in Transfer Factor and Dialyzable Leucocyte Extracts. Fujisawa T, Sasakawa S, Iikura Y, Komatsu F, Yamaguchi Y, Eds. Maruzen Co., LTD., Tokyo-1991.

88. Fiala M, et al. Clinical benefits and recovery of delayed-type hypersensitivity in patients with AIDS-related complex treated with IMREG-1 or placebo. Int J Immunopharmacol-1991. 13(7);999-1004

89. Gottlieb AA Clinical and immunologic observations in patients with

AIDS-related complex treated with IMREG-1. Int J Immunopharmacol-1991. 13 Suppl 1(0);29-32

90. Yang BZ, et al. Spleen cell dialyzable extracts (SCDE) mediated immunotherapy for patients with myasthenia gravis. Int J Immunopharmacol-1991. 13(7);825-9

91. Shizawa Y, et al. [An autopsied case of chronic active Epstein-Barr virus (EBV) infection with various symptom] Kansenshogaku Zasshi-1991. 65(4);481-7

92. Valdes Senchez AF, et al. [Atopic dermatitis. Treatment with transfer factor. A controlled clinical trial] Rev Alerg-1991. 38(6);158-62

93. Zackin RA, et al. Intention to treat analysis demonstrates IMREG-1 delays progression to AIDS in ARC patients in a six month trial. 6th Internation Conference on AIDS, San Francisco, CA-1990.

94. Neequaye J, et al. Specific transfer factor with activity against Epstein-Barr virus reduces late relapse in endemic Burkitt's lymphoma. Anticancer Res-1990. 10(5A);1183-7

95. Cabezas R, et al. Inmuterapia con Factor de Transferencia en pacientes con herpes zoster. Biotecnologia Aplicada-1990. 7;52-7

96. Stedry V, et al. [Manifestations of epidermolysis bullosa in the deglutition tract] Cesk Otolaryngol-1990. 39(4);199-203

97. Klein S, et al. [Alternatives to steroid therapy in chronic uveitis] Fortschr Ophthalmol-1990. 87(4);355-8

98. Gottlieb AA, Gottlieb MS Experience with IMREG-1, a leukocyte derived immunomodulator on candidiasis and progression of disease in patients with AIDS-related complex. In: Immunotherapeutic Prospects of Infectious Disease. Masihi KN, Lange W, Eds. Springer, NY-1990.

99. Guang-Shu Z, et al. Survey on the T-lymphocyte subsets transformation of hepatitis B patients treated with specific placenta transfer factor. In: Proceedings of the 4th Chinese Workshop on Transfer Factor. Science and Technology Press. Beijing-1990.

100. Guang-Shu Z, et al. Effects of specific placenta transfer factor on erythrocyte rosette formation and lymphocyte transformation tests of the hepatitis B patients. In: Proceedings of the 4th Chinese Workshop on Transfer Factor. Science and Technology Press. Beijing-1990.

101. Janout V, et al. An outbreak of viral hepatitis B associated with transfer factor administration. J Hyg Epidemiol Microbiol Immunol-1990. 34(1);31-6

102. McMeeking A, et al. A controlled trial of bovine dialyzable leukocyte extract for cryptosporidiosis in patients with AIDS. J Infect Dis-1990. 161(1);108-12

103. Guang-Shu Z, et al. Survey on the treatment of 200 cases of chornic hepatitis B with specific transfer factor extracted from HBVM positive placenta. Med J Chin People's Liberation Army-1990. 15(1);21

104. Lackovicova M, et al. Increased migration inhibition factor production by leukocytes of patients with herpes zoster given the leukocyte ultrafiltrate. Acta Virol-1989. 33(5);428-34

105. Vezendi S, Schroder I Transfer factor therapy of thoracic sarcoidosis. Allergol Immunopathol (Madr)-1989. 17(1);35-7

106. Perrick D, et al. Use of transfer factor in a pediatric AIDS patient with disseminated Mycobacterium avium intracellulare. Ann Allergy-1989. 62(5);437-40

107. Corrado F, et al. [Immunotherapy with transfer factor in hormone-resistant metastasized carcinoma of the prostate] Arch Esp Urol-1989. 42 Suppl 2(0);191-6

108. Sibl O, et al. [Non-differentiated carcinoma of the nasopharynx in children] Cesk Otolaryngol-1989. 38(2);121-7

109. Chng HH, et al. Inability of oral bovine transfer factor to eradicate cryptosporidial infection in a patient with congenital dysgammaglobulinemia. Clin Immunol Immunopathol-1989. 50(3);402-6

110. Cabeza-Quiroga R, et al. Effects of DLE in patients with herpes. In:

Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.

111. Han Y, et al. A control study of transfer factor and chlorpromazine in the treatment of schizophrenics. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.

112. Sonkoly I, et al. Treatment of SLE with transfer factor. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z,Eds. Xue Yuan Press, Beijing-1989.

113. Su CZ, Wan ZF Antigen-dependent activities and physio-chemical characterization of specific goat's transfer factor to human gastric adenocarcinoma. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.

114. Xie D, et al. Clinical observation of 37 cases of schizophrenia treated with transfer factor from bovine spleen. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.

115. Yan D, et al. The effect of DLE induced by psoriasis scale on psoriasis patients and their immunological function. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.

116. Zhan Y, et al. Transfer of Taekypleus Triclententus Hemocyanin and DNP-BSA dermal reactivity to human with goose derived transfer factor. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.

117. Zhang G, et al. Survey on the treatment of 200 CAH cases with specific transfer factor extracted from HBVM positive placenta. In: Research and Application of TF and DLE. Baolai H, Ruzhang W, Zhaofen Z, Eds. Xue Yuan Press, Beijing-1989.

118. [No Author(s)] Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group. J Neurol Neurosurg Psychiatry-1989. 52(5);566-74

119. Iseki M, et al. [Effects of transfer factor on chronic hepatitis B in childhood] Kansenshogaku Zasshi-1989. 63(12);1329-32

120. Zachar V, et al. Varicella-zoster virus IgG antibodies during primoinfection in competent and transfer factor modulated immunocompromised host: comparison of three indirect assays. Acta Virol-1988. 32(3);243-51

121. Miller LL, et al. A randomized, double-blind, placebo-controlled trial of transfer factor as adjuvant therapy for malignant melanoma. Cancer-1988. 61(8);1543-9

122. Hancock BW, et al. Transfer factor in Hodgkin's disease: a randomized clinical and immunological study. Eur J Cancer Clin Oncol-1988. 24(5);929-33

123. Yizhen F. Effects of transfer factor on 50 children with asthma. Practical and Clin J Pediatrics-1988. 3(3);146

124. Yonghua Han Liu Jiancheng, et al. A control study of transfer factor (TF) and chlopromazine in the treatment of schizophrenics. Reasearch and Application of Transfer Factor and DLE. Proceeding of the Sixth International Workshop on Transfer Factor Beijing Science Hall-1988.

125. Karl M, et al. [Clinical and immunologic results of immunotherapy with pooled buffy coat transfusions in females with habitual abortion] Z Geburtshilfe Perinatol-1988. 192(4);147-54

126. Zachariae H, Thestrup-Pedersen K Combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides: a six-year experience. Acta Derm Venereol-1987. 67(5);433-7

127. Mastromatteo V, et al. [Effects of transfer factor on the number of circulating lymphocytes in patients with spinocellular carcinoma of the cervicofacial area] Boll Soc Ital Biol Sper-1987. 63(11);1043-50

128. Negri L, et al. [Changes in circulating lymphocytes and "E" rosettes in patients with colonic neoplasms treated with transfer factor] Boll Soc Ital Biol Sper-1987. 63(11);1051-8

129. Jackson WB, et al. Laser therapy of conjunctival papillomas. Can J Ophthalmol-1987. 22(1);45-7

130. Wagner G, et al. Transfer factor for adjuvant immunotherapy in cervical cancer. Cancer Detect Prev Suppl-1987. 1(0);373-6

131. Louie E, et al. Treatment of cryptosporidiosis with oral bovine transfer factor. Clin Immunol Immunopathol-1987. 44(3);329-34

132. Iikura Y, et al. Clinical trial of human leukocyte extracts in allergic diseases and the study of their transfer factor content. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.

133. Mayer V, et al. Gel-Filtered ehtanol-precipitated material from human leukocyte ultrafiltrate in patients with herpes zoster. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.

134. Prochazkova J, et al. Clinical and immunological improvement in infants with HCMV infection treated with dialyzable leukocyte extract. In: Leukocyte Dialysates and Transfer Factor: Biological Studies and Clinical Investigations. Mayer V, Borvak J, Eds. Institute of Virology, Slovak Academy of Sciences, Bratislava.-1987.

135. Waisbren BA Observations on the combined systemic administration of mixed bacterial vaccine, bacillus Calmette-Guerin, transfer factor, and lymphoblastoid lymphocytes to patients with cancer, 1974-1985. J Biol Response Mod-1987. 6(1);1-19

136. Nkrumah FK, et al. Transfer factor in prevention of Burkitt's lymphoma relapses. J Exp Pathol-1987. 3(4);463-9

137. Viza D, et al. Use of specific transfer factor for the prevention or the treatment of herpes infections in mice and in man. J Exp Pathol-1987. 3(4);407-20

138. Viza D, et al. A preliminary report on three AIDS Patients treated with anti-HIV specific transfer factor. J Exp Pathol-1987. 3(4);653-9

139. Carey JT, et al. Augmentation of skin test reactivity and lymphocyte blastogenesis in patients with AIDS treated with transfer factor. JAMA-1987. 257(5);651-5

140. Wiersbitzky S, et al. Clinical results of transfer factor (BBZ Plauen) therapy in immunodeficient children. Padiatr Grenzgeb-1987. 26(6);439-41

141. Briese V, Richter C [Choriocarcinoma: neutropenia--acute emergency] Zentralbl Gynakol-1987. 109(7);450-8

142. Frith JA, et al. Transfer factor as a therapy for multiple sclerosis: a follow-up study. Clin Exp Neurol-1986. 22(0);149-54

143. Van Haver H, et al. Transfer factor therapy in multiple sclerosis: a three-year prospective double-blind clinical trial. Neurology-1986. 36(10);1399-402

144. Ashorn RG, et al. Dialysable leukocyte extracts (transfer factor) augment nonspecifically keyhole limpet haemocyanin and horseshoe crab haemocyanin skin reactivity in unimmunized human recipients. Scand J Immunol-1986. 23(2);161-7

145. Rytter M, et al. [Chronic mucocutaneous candida mycosis (CMCC) caused by a T-cell defect] Z Gesamte Inn Med-1986. 41(7);214-6

146. Ashorn R, et al. Cellular immunity in acne vulgaris during transfer factor treatment. Ann Clin Res-1985. 17(4);152-5

147. Goldenberg GJ, et al. Cooperative trial of immunotherapy for nasopharyngeal carcinoma with transfer factor from donors with Epstein-Barr virus antibody activity. Cancer Treat Rep-1985. 69(7-8);761-7

148. Misarova Z, et al. [Transfer factor in the treatment of children with disorders of cellular immunity] Cesk Pediatr-1985. 40(6);346-9

149. Gouyon JB, et al. Outbreak of respiratory syncytial virus in France. Eur J Clin Microbiol-1985. 4(4);415-6

150. Mowbray JF, et al. Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet-1985. 1(8435);941-3

151. Nkrumah F, et al. Regression of progressive lymphadenopathy in a young child with acute cytomegalovirus (CMV) infection following the administration of transfer factor with specific anti-CMV activity. Lymphokine Res-1985. 4(3);237-41

152. Viza D, et al. Orally administered specific transfer factor for the treatment of herpes infections. Lymphokine Res-1985. 4(1);27-30

153. Georgescu C Effect of long-term therapy with transfer factor in rheumatoid arthritis. Med Interne-1985. 23(2);135-40

154. Rosenberg SA, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med-1985. 313(23);1485-92

155. Fujisawa T [The results of immunotherapy as an adjunct to the surgical treatment of primary lung cancers] Nippon Geka Gakkai Zasshi-1985. 86(9);1055-8

156. Hong R, et al. Omenn disease: termination in lymphoma. Pediatr Pathol-1985. 3(2-4);143-54

157. Roda E, et al. Transfer factor for the treatment of HBsAg-positive chronic active hepatitis. Proc Soc Exp Biol Med-1985. 178(3);468-75

158. Borkowsky W, et al. Juvenile laryngeal papillomatosis with pulmonary spread. Regression following transfer factor therapy. Am J Dis Child-1984. 138(7);667-9 290. Kirsh MM, et al. Transfer factor in the treatment of carcinoma of the lung. Ann Thorac Surg-1984. 38(2);140-5

159. Wiedemann HP, et al. Progressive immune failure in dyskeratosis congenita. Report of an adult in whom Pneumocystis carinii and fatal disseminated candidiasis developed. Arch Intern Med-1984. 144(2);397-9

160. Aziz S, et al. Mucormycosis in patients with multiple-organ failure. Arch Surg-1984. 119(10);1189-91

161. Borkowsky W, Karpatkin S Leukocyte migration inhibition of buffy coats from patients with autoimmune thrombocytopenic purpura when exposed to normal platelets: modulation by transfer factor. Blood-1984. 63(1);83-7

162. Fujisawa T, et al. Adjuvant immunotherapy of primary resected lung cancer with transfer factor. Cancer-1984. 54(4);663-9

163. Strejcek J, JÃra M [The effect of transfer factor on phagocytosis and humoral immunity in children with recurrent otitis media] Cas Lek Cesk-1984. 123(32);1003

164. Kaminkova J, Lange CF Transfer factor and repeated otitis media. Cell Immunol-1984. 89(1);259-64

165. Schulkind ML, et al. A case report of the successful treatment of recurrent aphthous stomatitis with some preparations of orally administered transfer factor. Cell Immunol-1984. 84(2);415-21

166. Zielinski CC, et al. Dialyzable leukocyte extract (transfer factor) in the treatment of superinfected fistulating tuberculosis of the bone.Cell Immunol-1984. 84(1);200-5

167. Winkelmann RK, et al. Treatment of varicella-zoster pneumonia with transfer factor. Cutis-1984. 34(3);278-81

168. Corbeel L, et al. Immunological observations before and after successful treatment of chronic mucocutaneous candidiasis with

169. ketoconazole and transfer factor. Eur J Pediatr-1984. 143(1);45-8 170. Martinez MI, Sanchez JL Treatment of leprosy with weekly intravenous

infusion of leukocytes. Int J Dermatol-1984. 23(5);341-7 171. Franzoni E, et al. Behcet syndrome: report of two early-onset cases

treated with transfer factor. Ital J Neurol Sci-1984. 5(1);93-6 172. Vasily DB, et al. Epidermodysplasia verruciformis: response to therapy

with dialyzable leukocyte extract (transfer factor) derived from household contacts. J Clin Lab Immunol-1984. 14(1);49-57

173. Wilson GB, et al. Guidelines for immunotherapy of antigen-specific defects with transfer factor. J Clin Lab Immunol-1984. 13(2);51-8

174. Zhenqing F Observation of the skin delayed hypersensitivity response of transfer factor to patients with cancer. Jiangsu Med-1984.7;186

175. Fujisawa T, et al. Randomized controlled trial of transfer factor immunochemotherapy as an adjunct to surgical treatment for primary adenocarcinoma of the lung. Jpn J Surg-1984. 14(6);452-8

176. Rosenfeld F, et al. [Treatment of herpes infections with transfer factor] Presse Med-1984. 13(9);537-40

177. Dwyer JM, et al. Clinical and immunologic response to antigen-specific transfer factor in drug-resistant infection with Mycobacterium xenopi. Am J Med-1983. 74(1);161-8

178. Bukowski RM, et al. Randomized controlled trial of transfer factor in Stage II malignant melanoma. Cancer-1983. 51(2);269-72

179. Kamikova J, et al. [Te effect of transfer factor on phagocytosis and humoral immunity in children with recurrent middle ear inflammations] Cas Lek Cesk-1983. 122(51);1577-9

180. Kamikova J, et al. [The effect of the transfer factor on T lymphocytes in children with recurrent otitis media] Cas Lek Cesk-1983. 122(25);779-82

181. Tanphaichitra D Cellular immunity in typhoid fever, Legionnaires' disease, amebiasis: role of transfer factor and Levamisole in typhoid fever. Dev Biol Stand-1983. 53(0);35-40

182. Burton RC, et al. Effects of age, gender, and cigarette smoking on human immunoregulatory T-cell subsets: establishment of normal ranges and comparison with patients with colorectal cancer and multiple sclerosis. Diagn Immunol-1983. 1(3);216-23

183. Metzner G, et al. [Human transfer factor. II. Clinical results with the large pool transfer factor] Folia Haematol Int Mag Klin Morphol Blutforsch-1983. 110(4);526-39

184. Schutt C, et al. [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome] Folia Haematol Int Mag Klin Morphol Blutforsch-1983. 110(5);677-84

185. Fujisawa T, Yamaguchi Y [Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types] Gan No Rinsho-1983. 29(12);1409-16

186. Yamaguchi Y [Recurrence of lung cancer--its treatment and prevention] Gan No Rinsho-1983. 29(10);1063-71

187. Yamaguchi Y [Strategy and treatment of postoperative recurrence of primary lung cancer] Gan To Kagaku Ryoho-1983. 10(11);2258-67

188. Akashi K, et al. Clinical use of leukocyte dialysate (transfer factor) in Osaka area of Japan. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.

189. Ashorn RGI, et al. The effects of immune and nonimmune dialyzable leucocoyte extracts on KLH and HCH reactivity in unprimed human recipients: A double blind study. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.

190. Burger DR, et al. Human transfer factor: Specificity and structural models. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.

191. Fudenberg HH, et al. Clinical applications of the leukocyte migration inhibition assay: New methods for determining transfer factor potency

and for predicting clinical response. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.

192. Hainaut J, et al. Dialyzable leukocyte extracts in pulmonary diseases (lung cancer and recurrent bronchitis) In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.

193. Jones JF, et al. Oral bovine transfer factor (OTF) use in the hyper IgE syndrome In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.

194. Viza D, et al. Specific bovine transfer factor for the treatment of herpes infections. In: Immunobiology of Transfer Factor. Kirckpatrick CH, Burger DR, Lawrence HS, Eds. Academic Press, NY-1983.

195. Fudenberg HH, et al. Evaluation of potency and predictability of clinical response to DLE containing transfer factor. In: Immunomodulation and Thermotherapy. Fudenberg HH, Pontiggia P, Eds. Acta Medica; Rome-1983.

196. Chen WB, et al. Boosting effects of drugs benefiting vital energy and activating blood and transfer factor on the immunity of patients with chronic cor pulmonale. J Tradit Chin Med-1983. 3(1);63-6

197. Fujisawa T, et al. Transfer factor in restoration of cell mediated immunity in lung cancer patients. Jpn J Surg-1983. 13(4);304-11

198. Williamson MM, Gordon RD Severe chronic mucocutaneous candidiasis. Favourable response to oral therapy with ketoconazole. Med J Aust-1983. 1(6);276-8

199. Lang I, et al. [Enhancing decreased natural lymphocytotoxicity in tumor patients by transfer factor therapy] Orv Hetil-1983. 124(14);807-10

200. Jones JM, Craig WA Cryptococcal meningitis: resolution eight months after antifungal therapy. South Med J-1983. 76(12);1567-9

201. Wagner G, et al. [Transfer factor as adjuvant immunotherapy in invasive cervix cancer. Report of a double-blind study] Wien Klin Wochenschr-1983. 95(20);738-42

202. Jin A, et al. [Transfer factor therapy of viral hepatitis--report of 22 cases] Zhongguo Yi Xue Ke Xue Yuan Xue Bao-1983. 5(6);396-7

203. Bjerring P, et al. Treatment of Kaposi's varicelliform eruption wit adenine arabinoside (Vira-A) and transfer factor. Acta Derm Venereol-1982. 62(1);85-7

204. Thestrup-Pedersen K, et al. Transfer factor therapy in mycosis fungoides: a double-blind study. Acta Derm Venereol-1982.

205. 62(1);47-53 206. Zachariae H, et al. Oral retinoid in combination with bleomycin,

cyclophosphamide, prednisone and transfer factor in mycosis 207. fungoides. Acta Derm Venereol-1982. 62(2);162-4 208. Allen R, et al. Disseminated cryptococcosis after transurethral resection

of the prostate. Aust N Z J Med-1982. 12(4);296-9 209. Hersey P, et al. Deficient natural killer cell activity in a patient with

Fanconi's anaemia and squamous cell carcinoma. Association withdefect in interferon release. Clin Exp Immunol-1982. 48(1);205-12

210. Lang I, et al. Effect in vivo and in vitro treatment with dialyzable leukocyte extracts on human natural killer cell activity. Clin Immunol Immunopathol-1982. 25(1);139-44

211. Cameron J, et al. Severe tubulo-interstitial disease in a renal allograft due to cytomegalovirus infection. Clin Nephrol-1982. 18(6);321-5

212. Buck BE, et al. Measles virus panniculitis subsequent to vaccine administration. J Pediatr-1982. 101(3);366-73

213. Montie JE, et al. A critical review of immunotherapy of disseminated renal adenocarcinoma. J Surg Oncol-1982. 21(1);5-8

214. Georgescu C, Chirulescu Z Study of trace elements in patients with rheumatoid arthritis stage I-II, before and after treatment. Med Interne-1982. 20(4);271-5

215. Novitzky N, Jacobs P Acyclovir therapy in cutaneous herpes simplex following bone marrow transplantation. A case report. S Afr Med J-1982. 62(8);251-2

216. Jarisch R, et al. Influence of dialysable transfer factor on IgE concentrations in patients with atopic dermatitis. Allergy-1981. 36(2);99-105

217. Ortiz A, et al. [Transfer factor in the treatment of laryngeal papillomatosis. Apropos of 2 cases treated at the Caracas University Hospital] An Otorrinolaringol Ibero Am-1981. 8(4);289-94

218. Schwartz RA, Jeter WS Oral administration of human dialyzable transfer factor in a patient with psoriasis. Arch Dermatol-1981 117(1);3-4

219. Catanzaro A, et al. Transfer factor therapy for histoplasmosis in a patient with Hodgkin's disease. Arch Intern Med-1981. 141(4);533-7

220. Kauffman CA, et al. Invasive fungal infections in patients with chronic mucocutaneous candidiasis. Arch Intern Med-1981. 141(8);1076-9

221. Tamari H, et al. An acute variant of subacute sclerosing panencephalitis: an autopsy case report. Brain Dev-1981. 3(1);87-91

222. Blume MR, et al. Adjuvant immunotherapy of high risk stage I melanoma with transfer factor. Cancer-1981. 47(5);882-8

223. Lamoureux G, et al. A clinical and immunological study of the effects of transfer factor on multiple sclerosis patients. Clin Exp Immunol-1981. 43(3);557-64

224. Delgado O, et al. Dialyzable leukocyte extract therapy in immunodepressed patients with cutaneous leishmaniasis. Clin Immunol Immunopathol-1981. 19(3);351-9

225. Khan A, et al. Transfer factor in the treatment of herpes simplex types 1 and 2. Dermatologica-1981. 163(2);177-85

226. Goring HD [IgA deficiency in the dermatologic clinic. Frequency, clinical relevance, diagnosis and therapy] Hautarzt-1981. 32(10);505-11 360. Pizza G, et al. The possible use of specific transfer factor in the treatment of patients with nasopharyngeal carcinoma. In: Nasopharyngeal Carcinoma. Grundman E, Krueger GRF, Ablashi DV, Eds. Fisher-Verlag Editor, Stuttgart-1981.

227. Moulias R, et al. Human dialysable leucocyte extracts (transfer factor) in interstitial pneumonia. A retrospective trial in immunodeficient patients. J Clin Lab Immunol-1981. 6(1);13-6

228. Jones JF, et al. Treatment of childhood combined Epstein-Barr virus/cytomegalovirus infection with oral bovine transfer factor. Lancet-1981. 2(8238);122-4

229. Gilchrist GS, et al. Management of osteogenic sarcoma: a perspective based on the Mayo Clinic experience. Natl Cancer Inst Monogr-1981.

230. Yamaguchi Y [Effect of transfer factor on surgical treatment of primary lung cancer] Rinsho Kyobu Geka-1981. 1(3);397-405

231. Berezhnaia NM, et al. [Transfer factor immunotherapy of oncological patients] Vopr Onkol-1981. 27(2);89-91

232. Jensen JR, Thestrup-Pedersen K Subpopulations of T lymphocytes in a patient with fulminant mycosis fungoides. Acta Derm Venereol-1980. 60(2);159-61

233. Mobacken H, et al. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study. Acta Derm Venereol-1980. 60(1);51-5

234. Kyong CU, et al. Chorioretinitis with a combined defect in T and B lymphocytes and granulocytes. A new syndrome successfully treated with dialyzable leukocyte extracts (transfer factor). Am J Med-1980. 68(6);955-61

235. De Bruyere M, et al. HLA haplotypes and long survival in childhood acute lymphoblastic leukaemia treated with transfer factor. Br J Haematol-1980. 44(2);243-51

236. Abramson A, et al. Immunocompetence and transfer factor therapy in

uveitis. Br J Ophthalmol-1980. 64(5);332-8 237. Gonzalez RL, et al. Adjuvant immunotherapy with transfer factor in

patients with melanoma metastatic to lung. Cancer-1980. 45(1);57-63 238. Schwarz MA, et al. Chemoimmunotherapy of disseminated malignant

melanoma with DTIC-BCG, transfer factor + melphalan. Cancer-1980. 45(10);2506-15

239. Steele RW Transfer factor and cellular reactivity to varicella-zoster antigen in childhood leukemia. Cell Immunol-1980. 50(2);282-9

240. Spitler LE Transfer factor: failure to transfer reactivity in normal human subjects. Clin Exp Immunol-1980. 39(3);708-16

241. Khan A, et al. Transfer factor treatment in bullous pemphigoid. Impaired T cell function. Dermatologica-1980. 161(4);243-9

242. Zachariae H, et al. Transfer factor in mycosis fungoides: three years experience. Dermatologica-1980. 160(1);1-6

243. Leser PG, et al. Cell mediated immunity in patients with Virchowian hanseniasis before and after treatment with transfer factor. Hansenol Int-1980. 5(1);3-27

244. Stubbs EG, et al. Transfer factor immunotherapy of an autistic child with congenital cytomegalovirus. J Autism Dev Disord-1980. 10(4);451-8

245. Landwehr DM, et al. Rapidly progressive glomerulonephritis in Behcet's syndrome. JAMA-1980. 244(15);1709-11

246. Fujisawa T, et al. Effect of transfer factor in the primary resected, lung cancer patients with secondary immunodeficiency due to chemotherapy. Jpn J Cancer Chemother-1980. 7(11);2004-11

247. Basten A, et al. Transfer factor in treatment of multiple sclerosis. Lancet-1980. 2(8201);931-4

248. Thestrup-Pedersen K, et al. Epstein-Barr-virus-induced lymphoproliferative disorder converting to fatal Burkitt-like lymphoma in a boy with interferon-inducible chromosomal defect. Lancet-1980. 2(8202);997-1002

249. Kornblut AD An evolution of therapy for mucocutaneous candidiasis. Laryngoscope-1980. 90(7 Pt 2 Suppl 22);1-30

250. Simo-Camps E, et al. [Cell immunity responses in patients with widespread neoplasias following administration of transfer factor (author's transl)] Med Clin (Barc)-1980. 74(10);403-7

251. dos Reis VL, et al. [Transfer factor in diffuse cutaneous leishmaniasis. Experience with one case] Med Cutan Ibero Lat Am-1980. 8(4-6);95-100

252. Keith CG, La Nauze J Cytomegalovirus retinitis. Med J Aust-1980. 1(1);24-6

253. Franchi F, et al. [Clinico-immunological studies of 32 cases of bone tumors] Minerva Med-1980. 71(25);1815-22 388. Steele RW, et al. Transfer factor for the prevention of varicella-zoster infection in childhood leukemia. N Engl J Med-1980. 303(7);355-9

254. Spitler LE, et al. Nephropathy in the Wiskott-Aldrich syndrome. Pediatrics-1980. 66(3);391-8

255. Olding-Stenkvist E, et al. Fatal progressive vaccinia in two immunodeficient infants. Scand J Infect Dis Suppl-1980. Suppl 24(0);63-7

256. Han SH, et al. Conversion of reactions to leprolin and lepromin in patients with lepromatous leprosy by the transfer factor. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi-1980. 13(1);1-8

257. Zachariae H, et al. Transfer factor in mycosis fungoides: a case report on a patient "cured". Acta Derm Venereol-1979. 59(4);375-8

258. Spitler LE Transfer factor therapy in the Wiskott-Aldrich syndrome. Results of long-term follow-up in 32 patients. Am J Med-1979. 67(1);59-66

259. Hainaut J, et al. [Effect of transfer factor on the immunity state of patients with bronchopulmonary cancer. A report on 12 cases (author's

transl)] Ann Med Interne (Paris)-1979. 130(11);517-21 260. Olarte MR, et al. Transfer factor is ineffective in amyotrophic lateral

sclerosis. Ann Neurol-1979. 5(4);385-8 261. Horsmanheimo M, et al. Immunologic features of chronic

granulomatous mucocutaneous candidiasis before and after treatment with transfer factor. Arch Dermatol-1979. 115(2);180-4

262. Manz HJ, et al. Delayed radiation necrosis of brainstem related to fast neutron beam irradiation: case report and literature review. Cancer-1979. 44(2);473-9

263. Burger DR, et al. Transfer of keyhole limpet hemocyanin dermal reactivity to man with bovine transfer factor. Cell Immunol-1979. 43(1);192-6

264. Shulman ST, et al. A double-blind evaluation of transfer factor therapy of HBsAg-positive chronic aggressive hepatitis: preliminary report of efficacy. Cell Immunol-1979. 43(2);352-61

265. Ellis-Pegler R, et al. Transfer factor and hepatitis B: a double blind study. Clin Exp Immunol-1979. 36(2);221-6

266. Faber WR, et al. A placebo controlled clinical trial of transfer factor in lepromatous leprosy. Clin Exp Immunol-1979. 35(1);45-52

267. Kesarwala HH, et al. Transfer factor therapy in hyperimmunoglobulinaemia E syndrome. Clin Exp Immunol-1979. 36(3);465-72

268. Nekam K, et al. Effects of therapy with dialyzable leukocyte extracts containing transfer factor activity on antibody-dependent

269. cytotoxic activity in humans. Clin Immunol Immunopathol-1979. 13(4);407-12

270. Sharma MK, et al. Preliminary results of transfer factor therapy of persistant cutaneous leishmania infection. Clin Immunol Immunopathol-1979. 12(2);183-90

271. Vicary FR, et al. Double-blind trial of the use of transfer factor in the treatment of Crohn's disease. Gut-1979. 20(5);408-13

272. Schut BJ, et al. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study. Immunology-1979. 36(1);1-12

273. Berkel AI, et al. Transfer factor therapy in ataxia-telangiectasia: A 3 year follow-up. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

274. Bukowski RM, et al. Immunotherapy of stage II malignant melanoma and renal cell carcinoma with transfer factor in clinical results. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

275. Freedman RS, et al. Experiences with TFd in advanced gynecological cancer and two non-gynecological sarcomas. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

276. Grob PJ, et al. Clinical trials with transfer factor preparations Zurich (TFz) -7 series of patients. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

277. Heim LR Atopic dermatitis, specific virus infections, and Behcet's syndrome: Transfer factor therapy. In: Immune Regulators in: Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

278. Jeter WS, et al. Oral administration of bovine and human dialyzable transfer factor to human volunteers. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

279. Khan A, et al. Management of viral infections with transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

280. Kirkpatrick CH, Greenberg LE Treatment of chronic mucocutaneous

candidiasis with transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

281. Nekam K, et al. Effect of transfer factor therapy on antibody-dependent cytotoxic activity in humans. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

282. Peetoom F, Florey MJ. Transfer factor in the treatment of disseminated herpes zoster (Hz) infection in immune-suppressed patients. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

283. Phillips TM, et al. Variation of antitumor antibodies in patients treated with transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

284. Rodriguez GE, et al. Treatment of Behcet's disease with transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

285. Rovensky J, et al. Transfer factor treatment in patients with psoriasis. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

286. Sharma M, et al. Transfer factor therapy in human cutaneous leishmania infection (CLI). In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

287. Silverman M, et al. Transfer factor in the treatment of B-cell disorders: Effects and potential risks. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

288. South MA, Caleb M Intravenous long term transfer factor therapy. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

289. Steele RW Passive transfer of reactivity to varicella-zoster in the compromised host. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

290. Vich JM, et al. Transfer to man of sensitisation to keyhole limpet haemocyanin by mouse transfer factor. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

291. Zachariae H, et al. Transfer factor as an additional therapeutic agent in mycosis fumgoides. In: Immune Regulators in Transfer Factor. Khan A, Kirkpatrick CH, Hill NO, Eds. Academic Press, NY-1979.

292. Epstein WL, Byers VS Transfer of contact sensitivity to beryllium using dialyzable leukocyte extracts (transfer factor). J Allergy Clin Immunol-1979. 63(2);111-5

293. Kirsh MM, et al. Clinical presentation and management of patients with carcinoma of the lung: a 14-year experience. J Fam Pract-1979. 8(6);1127-31

294. Plouffe JF, et al. Cell-mediated immune responses in sporotrichosis. J Infect Dis-1979. 139(2);152-7

295. Lankford J, et al. A case of varicella pneumonia treated with transfer factor. JAMA-1979. 241(24);2598

296. Sodomann CP, et al. [Transfer factor (TF) treatment of patients with HBs-Ag-positive chronic active hepatitis. A prospective, controlled study (author's transl)] Klin Wochenschr-1979. 57(17);893-903

297. Ketchel SJ, et al. A study of transfer factor for opportunistic infections in cancer patients. Med Pediatr Oncol-1979. 6(4);295-301

298. Endre L, et al. [Successful treatment of Wiscott-Aldrich syndrome with transfer factor] Orv Hetil-1979. 120(39);2361-6

299. [No Author(s)] [Prevention of infection in patients with chronic obstructive pulmonary disease by normal human tonsillar transfer factor (author's transl)] Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi-1979. 2(1);25-7

300. Romano EL, et al. [Treatment of patients with multiple sclerosis with

transfer factor (author's transl)] Acta Cient Venez-1978. 29(1);49-52 Grohn P, et al. The effect of transfer factor on cystic acne. Acta Derm Venereol-1978. 58(2);153-5

301. Hovmark A, Ekre HP Failure of transfer factor therapy in atopic dermatitis. Acta Derm Venereol-1978. 58(6);497-500

302. Hastings RC, Job CK Reversal reactions in lepromatous leprosy following transfer factor therapy. Am J Trop Med Hyg-1978. 27(5);995-1004

303. Khan A, et al. The usefulness of transfer factor in asthma associated with frequent infections. Ann Allergy-1978. 40(4);229-32

304. Hoyeraal HM, et al. No effect of transfer factor in juvenile rheumatoid arthritis by double-blind trial. Ann Rheum Dis-1978. 37(2);175-9

305. Spitler LE, et al. Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis. Arch Dermatol-1978. 114(10);1501-4

306. Mackie RM, et al. Wiskott-Aldrich syndrome with partial response to transfer factor. Br J Dermatol-1978. 98(5);567-71

307. Phillips J, et al. Effect of in vitro produced transfer factor on Hodgkin patients. Br J Haematol-1978. 38(3);430-1

308. Danoff D, et al. Disseminated coccidioidomycosis: clinical, immunologic and therapeutic aspects. Can Med Assoc J-1978. 118(4);390-2

309. FitzSimons RB, Ferguson AC Cellular immunity and nutrition in refractory disseminated blastomycosis. Can Med Assoc J-1978. 119(4);343-6

310. Gilchrist GS, et al. Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy. Cancer Treat Rep-1978. 62(2);289-94

311. Collins RC, et al. A double-blind trial of transfer factor vs placebo in multiple sclerosis patients. Clin Exp Immunol-1978. 33(1);1-11

312. Sharma MK, et al. Progressive BCG infection in an immunodeficient child treated with transfer factor. Clin Immunol Immunopathol-1978. 10(4);369-80

313. Wolf RE, et al. Transfer factor therapy in a case of pemphigus vegetans associated with chronic mucocutaneous candidiasis. Clin Immunol Immunopathol-1978. 10(3);292-7

314. Ritts RE, et al. Comparison of transfer factor and combination chemotherapy as post surgical adjuvants in osteogenic sarcoma: Results at 3 years. In: Immunotherapy of Malignant Disease. Rainer H, Borberg H, Mishler JM, Schafer U, Eds. FK Schattauer Verlag, NY-1978.

315. Timar L, et al. Progressive vaccinia: immunological aspects and transfer factor therapy. Infection-1978. 6(4);149-53

316. Krown SE, et al. Effects of transfer factor in patients with advanced cancer. Isr J Med Sci-1978. 14(10);1026-38

317. Neidhart JA, et al. Skin test conversion following transfer factor. A double-blinded study of normal individuals. J Allergy Clin

318. Immunol-1978. 61(2);115-8 319. Virelizier JL, et al. Impaired defense against vaccinia in a child with T-

lymphocyte deficiency associated with inosine phosphorylase defect. J Pediatr-1978. 92(3);358-62

320. Gross PA, et al. Disseminated Cryptococcus treated with transfer factor. JAMA-1978. 240(22);2460-2

321. Fog T, et al. Long-term transfer-factor treatment for multiple sclerosis. Lancet-1978. 1(8069);851-3

322. Vich JM, et al. Transfer to man of sensitisation to keyhole limpet haemocyanin by mouse transfer factor. Lancet-1978. 1(8058);265-6

323. Vetto RM, Burger DR Transference of cell mediated immunity in patients with head and neck cancer. Laryngoscope-1978. 88(1 Pt 2 Suppl 8);79-82

324. Maida E, et al. [Transfer-factor therapy in a case of chronic herpes

simplex myelitis (author's transl)] Nervenarzt-1978. 49(11);671-3 325. Horn GV, et al. Progressive multifocal leukoencephalopathy: failure of

response to transfer factor and cytarabine. Neurology-1978. 28(8);794-7 326. Nekam K, et al. [Therapeutic experience with transfer factor in 18

cases] Orv Hetil-1978. 119(29);1787-91 327. Kyong CU, et al. X-linked immunodeficiency with increased IgM: clinical,

ethnic, and immunologic heterogeneity. Pediatr Res-1978. 12(10);1024-6

328. Winsnes R, et al. Effect of transfer factor and zoster immunoglobulin in patients with varicella-zoster infection and malignancy.

329. Scand J Infect Dis-1978. 10(1);21-7 330. Rainer H, et al. [Randomized study: chemotherapy versus

chemotherapy plus transfer factor in metastasized breast neoplasm] Verh Dtsch Ges Inn Med-1978.

331. Thulin H, et al. Long-term transfer factor treatment in severe atopic dermatitis. Acta Allergol-1977. 32(4);236-7

332. Mobacken H, et al. Deficient neutrophil function in a patient with chronic mucocutaneous candidiasis, thymoma and myasthenia gravis. Acta Derm Venereol-1977. 57(4);335-9

333. Offner H, et al. Lymphocyte stimulation in multiple sclerosis patients untreated and treated with transfer factor. Long-term studies on the effect of different stimulants on myo-(2-3H)inositol incorporation into phosphatidylinositol of lymphocytes. Acta Neurol Scand-1977. 56(6);465-74

334. Espinoza LR, et al. Cell-mediated immunity in multiple sclerosis. Acta Neurol Scand Suppl-1977. 63(0);123-31

335. Jersild C, et al. Transfer factor treatment of multiple sclerosis. A pilot study. Acta Neurol Scand Suppl-1977. 63(0);253-64

336. Spitler LE, Dau PC Immunotherapy in infectious disease, autoimmunity and cancer. Acta Neurol Scand Suppl-1977. 63(0);227-37

337. Anttila R, et al. Transfer factor and cellular immune response in urinary tract infections in children. Acta Paediatr Scand-1977.66(2);219-24

338. Grohn P Transfer factor in chronic and recurrent respiratory tract infections in children. Acta Paediatr Scand-1977. 66(2);211-7

339. Pedersen FK, et al. Indication of primary immune deficiency in Fanconi's anemia. Acta Paediatr Scand-1977. 66(6);745-51

340. Benz CC, et al. Acquired chronic candidiasis treated with transfer factor. Br J Dermatol-1977. 97(1);87-91

341. Berkel AI, et al. Transfer factor therapy in ataxia--telangiectasia. Clin Exp Immunol-1977. 29(3);376-84

342. Jain S, et al. Transfer factor in the attempted treatment of patients with HBsAg-positive chronic liver disease. Clin Exp Immunol-1977.30(1);10-5

343. Rubinstein A, et al. Transfer factor treatment in a patient with progressive tuberculosis. Clin Immunol Immunopathol-1977. 8(1);39-50

344. Espanol T, et al. Neuroblastoma and transfer factor. Dev Biol Stand-1977. 38(0);331-3

345. Pizza G, et al. Effect of in vitro produced transfer factor on the immune response of cancer patients. Eur J Cancer-1977. 13(9);917-23

346. Lawton JW, et al. Human transfer factor prepared by dialysis, ultrafiltration and gel chromatography: biological activity in local transfer of skin sensitivity. J Immunol Methods-1977. 16(2);119-29

347. Horsmanheimo M, et al. Clinical study of a patient with lupus vulgaris before and after injection of dialyzable transfer factor. J Invest Dermatol-1977. 68(1);10-5

348. Sieber OF, et al. Coccidioides immitis osteomyelitis of the mandible in an infant. J Oral Surg-1977. 35(9);721-5

349. Jeter WS, et al. Oral administration of dialyzable transfer factor to tuberculin to human volunteers. J Reticulo Endothel Soc-1977. 22;46a

350. Montie JE, et al. Immunotherapy of disseminated renal cell carcinoma

with transfer factor. J Urol-1977. 117(5);553-6 351. Wolf RE, et al. Treatment of Behcet's syndrome with transfer factor.

JAMA-1977. 238(8);869-71 352. Boucheix C, et al. Activity of animal transfer factor in man. Lancet-1977.

1(8004);198-9 353. Thomas IT, et al. Transfer-factor treatment in congenital

cytomegalovirus infection. Lancet-1977. 2(8047);1056-7 354. Garcia-Calderon PA, et al. [Therapy with transfer factor in a case of

recidivating herpes with polymorphous erythema] Med Cutan Ibero Lat Am-1977. 5(5);361-6

355. Balsamo V, et al. [Preliminary experience with the treatment of a case of Wiskott-Aldrich syndrome with transfer factor] Minerva Pediatr-1977. 29(10);651-5

356. Sutherland DC, et al. Transfer factor therapy: clinical experience and the role of the E rosette assay. N Z Med J-1977. 85(579);3-6

357. Fukawa O, et al. [Cytotoxic activity of lymphocyte in patients with brain tumor and its augmentation effect by transfer factor (author's transl)] Neurol Med Chir (Tokyo)-1977. 17(2 pt. 2);115-22

358. Dammacco F, et al. Immune function in patients with multiple myeloma (delayed cutaneous reactivity and lymphocytes bearing receptors for sheep, human and mouse erythrocytes). Ric Clin Lab-1977. 7(4);343-53

359. Ng RP Disseminated varicella infec

Date post:	09-Jul-2020
Category:	Documents
Upload:	others
View:	5 times
Download:	0 times

REFERENCIAS Biologic response modifiers in primary ... referenci… · Biologic response modifiers...

Documents